A public recall advisory has recently been released by the Medical Benefits Scheme (MBS) targeting individuals who collected 10mg or 20mg doses of the cholesterol-lowering medication Atorvastatin from an MBS-affiliated pharmacy in June 2026.
All beneficiaries affected by this advisory are urged to carefully review the official notification, cross-check the lot number printed on their medication packaging against the ranges listed in the recall notice, and follow the step-by-step return and replacement protocols outlined by the scheme.
To make the return process more convenient for patients who may be unable to visit during standard weekday operating hours, the MBS Nevis Street Pharmacy will open for extended hours on Saturday, August 22, 2026, accepting recalled medication between 9:00 a.m. and 2:00 p.m.
Importantly, this recall only impacts the specific pre-identified lots of Atorvastatin. The advisory explicitly reminds beneficiaries that they should not stop taking their prescribed medication before seeking guidance from a licensed physician, nurse, or practicing pharmacist, to avoid adverse health impacts from interrupted treatment.